Related Experiment Videos
Recurrent cytogenetic aberrations in human ovarian carcinomas
M Kiechle-Schwarz1, T Bauknecht, J Schmidt
1Department of Gynecology and Obstetrics, Albert-Ludwigs University, Freiburg, Germany.
Cancer Detection and Prevention
|January 1, 1995
Summary
Cytogenetic analysis of ovarian tumors revealed clonal chromosome abnormalities in 23 cases. Recurrent changes include losses of chromosomes 1, X, 17 and gains of chromosomes 12, 20, with specific alterations at 11p13-14 and a 19p+ marker.
Area of Science:
- Oncology
- Genetics
- Cytogenetics
Background:
- Ovarian carcinomas are heterogeneous malignancies.
- Understanding their genetic underpinnings is crucial for diagnosis and treatment.
- Cytogenetic analysis provides insights into chromosomal alterations in cancer.
Purpose of the Study:
- To investigate clonal chromosome abnormalities in malignant ovarian tumors.
- To identify recurrent numerical and structural aberrations.
- To correlate findings with existing literature on ovarian carcinoma cytogenetics.
Main Methods:
- Short-term cultures of 62 malignant ovarian tumors.
- Karyotyping to analyze chromosome number and structure.
- Identification of clonal and nonclonal abnormalities.
Main Results:
- Clonal chromosome abnormalities were found in 23 of 62 tumors.
- Common numerical imbalances: loss of chromosomes 1, X, 17; gain of chromosomes 12, 20.
- Frequent structural rearrangements involved 11p13-14 (deletion, translocation) and a 19p+ marker chromosome.
Conclusions:
- Malignant ovarian tumors exhibit diverse cytogenetic profiles.
- Specific recurrent aberrations, including 11p alterations and a 19p+ marker, are consistent findings.
- These cytogenetic markers may aid in understanding ovarian carcinoma development.